Michael Gandal is the Hetznecker Associate Professor in Psychiatry at the University of Pennsylvania and a member of the Lifespan Brain Institute at the University of Pennsylvania Perelman School of Medicine and the Children’s Hospital of Philadelphia. As a psychiatrist, he specializes in the treatment of adolescents and adults with neurodevelopmental and psychiatric conditions, including autism, attention deficit hyperactivity disorder (ADHD), bipolar disorder and schizophrenia.
Gandal directs a developmental neurogenomics research laboratory which leverages large-scale genetic and genomic approaches to better understand the biological mechanisms contributing to — and novel treatment approaches for — neurodevelopmental and psychiatric conditions.
Gandal received his B.S. in engineering (biomedical computation) from Stanford University and his M.D./Ph.D. in bioengineering from the University of Pennsylvania. He completed residency training in psychiatry at the University of California, Los Angeles, and a postdoctoral fellowship in neurogenetics in the laboratory of Daniel Geschwind, characterizing the genetic contributions to shared gene expression alterations in the human brain across several major psychiatric disorders.